ClearBridge Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCE
CC
MF
BCM
FCM
ClearBridge Investments's ONCE Position: Q1 2019 in Review
ClearBridge Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 658,396 shares — an estimated $25.8M sold.
ClearBridge Investments first reported a position in ONCE in Q1 2015 and held it in 16 quarters. The position peaked at $59.6M in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.
- ClearBridge Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
- ClearBridge Investments sold 658,396 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $25.8M.
- ClearBridge Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 16 quarters.
- ClearBridge Investments's Spark Therapeutics, Inc. Common Stock position peaked at $59.6M in Q3 2017.
- 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.
Based on ClearBridge Investments's 13F filing for Q1 2019, filed 15 May 2019.